Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia

Fig. 5

Kaplan-Meier survival curves representing time to first treatment (TTFT) in early stage CLL patients with a low (n = 47) and high (n = 46) mRNA expression of CRY1 b low (n = 46) and high (n = 46) mRNA expression of PAX9 and; c unmutated (n = 39) and mutated IGHV genes (n = 54)

Back to article page